Skip to the content
Loading
0
logo mainlogo darklogo light
  • Home
  • About Us
  • Products
  • Our Team
  • Contact Us
support@example.com
0

No products in the cart.

logo main
0

No products in the cart.

  • Home
  • About Us
  • Products
  • Our Team
  • Contact Us
HomeLandingCentral Nervous SystemADHD Combination Asset
Popular
ADHD Combination Asset
ADHD Combination Asset

Triple Reuptake Inhibitor

Stage:NDA Submitted

A triple reuptake inhibitor for ADHD, non-controlled and non-doping, addressing abuse risk, dose-response variability, and the emotional dimension gap of current therapies.

  • Non-controlled formulation
  • Non-doping compliant
  • Addresses abuse risk
  • Fills emotional dimension gap
Target Launch:NDA in Review
Category:Central Nervous System

Related items

  • Essential Tremor ProgramPopular
    Essential Tremor Program Read more
  • Insomnia MedicationPopular
    Insomnia Medication Read more
About us

Fit light Medtech exists to change the way high-prevalence, refractory conditions are treated — through scientific innovation and patient-centered development.

Navigation
  • Home
  • About Us
  • Products
  • Our Team
  • Contact Us
Contact Us
  • +86 25 5230 0099
  • BD@taneinbio.com
  • Building No. 11, South Tower, Room 444, Ludi Vanke Yun Duhui, Qixia District, Nanjing, Jiangsu, China
Follow us